Literature DB >> 23520046

Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.

Kangdi Zhu1, Jacobus J van Hilten, Hein Putter, Johan Marinus.   

Abstract

The aim of this study was to identify risk factors for the development of hallucinations in patients with Parkinson's disease (PD). A broad range of motor and nonmotor features was assessed at baseline and during the following 5 years in 386 PD patients. Cross-sectional analyses of baseline data and longitudinal analyses of follow-up data were performed to identify risk factors for hallucinations in PD. Twenty-one percent of the patients had hallucinations at baseline, whereas 46% of the patients without hallucinations at baseline developed this feature during follow-up. Univariate survival analysis showed that older age, female sex, less education, higher age at onset, and more severe motor and cognitive impairment, depression, daytimes sleepiness, autonomic dysfunction, and motor fluctuations and dyskinesias, as well as higher daily levodopa dose, were associated with the risk of developing hallucinations. This largely corresponds with the features that were associated with the presence of hallucinations at baseline. In a stepwise regression model, older age at onset, female sex, excessive daytime sleepiness, autonomic dysfunction, and dyskinesias emerged as independent risk factors for developing hallucinations. Female sex, autonomic dysfunction, motor fluctuations, and dyskinesias have not been reported as risk factors in previous studies. These findings lend support to the notion that hallucinations in PD are caused by a combination of risk factors that are associated with (the interaction between) older age and more advanced disease. The identification of female sex as a risk factor for developing of hallucinations in PD is a new finding and should be verified in future studies.
Copyright © 2013 Movement Disorder Society.

Entities:  

Mesh:

Year:  2013        PMID: 23520046     DOI: 10.1002/mds.25389

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  23 in total

Review 1.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

Review 2.  Predictors of cognitive impairment in Parkinson's disease: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Yu Guo; Feng-Tao Liu; Xiao-He Hou; Jie-Qiong Li; Xi-Peng Cao; Lan Tan; Jian Wang; Jin-Tai Yu
Journal:  J Neurol       Date:  2020-03-12       Impact factor: 4.849

Review 3.  Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Authors:  Abhishek Lenka; Javier Pagonabarraga; Pramod Kumar Pal; Helena Bejr-Kasem; Jaime Kulisvesky
Journal:  Neurology       Date:  2019-07-09       Impact factor: 9.910

Review 4.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

Review 5.  Treatment of Sleep Dysfunction in Parkinson's Disease.

Authors:  Amy W Amara; Lana M Chahine; Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2017-07       Impact factor: 3.598

Review 6.  Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.

Authors:  Shyam C Panchal; William G Ondo
Journal:  Curr Psychiatry Rep       Date:  2018-01-27       Impact factor: 5.285

7.  Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.

Authors:  Giuseppe Tosto; Sarah E Monsell; Stephen E Hawes; Giuseppe Bruno; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 8.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 9.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

10.  Predictable Risk Factors for the Feeling of Presence in Patients with Parkinson's Disease.

Authors:  Hiroshi Kataoka; Satoshi Ueno
Journal:  Mov Disord Clin Pract       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.